CNC.NYSECentene CORP

Form 4: Centene Director Kenneth Burdick Acquires Shares and Options in Year-End Transaction

Sentiment:

SEC Form 4 Filing


Director Kenneth Burdick acquired 497 shares of Centene stock and holds options for 10,000 shares, according to a recent SEC filing.

Summary

  • Kenneth Burdick, a director at Centene Corp, acquired 497 shares of common stock on December 31, 2024.
  • The acquisition was made at a price of $0 per share, which may indicate a grant or award rather than a purchase.
  • Following the transaction, Mr. Burdick directly owns 362,417.924 shares, which includes 2,916 restricted stock units.
  • He also indirectly owns 86,498 shares through the Burdick Family LLC.
  • Mr. Burdick also holds options to purchase 10,000 shares of Centene stock at an exercise price of $80.57, exercisable from February 7, 2025, and expiring on February 7, 2032.

Sentiment

Score: 7

Explanation: The document reflects a routine insider transaction, which is generally viewed positively as it indicates director confidence. The acquisition of shares and options is a positive sign, but it's not a major event that would drastically alter sentiment.

Positives

  • The acquisition of shares by a director can be seen as a positive sign of confidence in the company's future.
  • The grant of options indicates a long-term incentive for the director to contribute to the company's success.

Management Comments

  • Mr. Burdick disclaims beneficial ownership of the shares held by the Burdick Family LLC except to the extent of his pecuniary interest.

Industry Context

This filing is a routine disclosure of insider transactions, which is common for publicly traded companies. It provides transparency into the holdings of company directors.

Comparison to Industry Standards

  • SEC Form 4 filings are standard practice for publicly traded companies in the US, ensuring transparency of insider transactions.
  • The acquisition of shares and options by a director is a common form of compensation and incentive in the corporate world.
  • The specific details of the transaction, such as the $0 acquisition price and the option exercise price, are specific to Centene and its compensation policies.

Stakeholder Impact

  • The transaction may have a minor positive impact on shareholder sentiment, as it indicates director confidence in the company.

Key Dates

DateDescription
12/31/2024Date of the stock acquisition and option grant.
02/07/2025Date the stock options become exercisable.
02/07/2032Expiration date of the stock options.
01/03/2025Date the SEC Form 4 was signed.

Keywords

Centene, CNC, Kenneth Burdick, Director, SEC Form 4, Stock Acquisition, Stock Options, Beneficial Ownership, Insider Trading

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.